Structure-based pharmacophore modeling 2. Developing a novel framework for structure-based pharmacophore model generation and selection

被引:1
|
作者
Szwabowski, Gregory L. [1 ]
Daigle, Bernie J. [2 ,3 ]
Baker, Daniel L. [1 ]
Parrill, Abby L. [1 ]
机构
[1] Univ Memphis, Dept Chem, Memphis, TN 38152 USA
[2] Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA
[3] Univ Memphis, Dept Comp Sci, Memphis, TN 38152 USA
关键词
Pharmacophore modeling; Ligand identification; Ligand discovery; Structure-based pharmacophore; GPCR; PROTEIN-COUPLED RECEPTORS; OPIOID RECEPTOR; CRYSTAL-STRUCTURE; DRUG DISCOVERY; ADENOSINE A(1); FINGERPRINTS; CHALLENGES; COMPLEX; TARGETS; LIGAND;
D O I
10.1016/j.jmgm.2023.108488
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Pharmacophore models are three-dimensional arrangements of molecular features required for biological activity that are used in ligand identification efforts for many biological targets, including G protein-coupled receptors (GPCR). Though GPCR are integral membrane proteins of considerable interest as targets for drug development, many of these receptors lack known ligands or experimentally determined structures necessary for ligand-or structure-based pharmacophore model generation, respectively. Thus, we here present a structure-based pharmacophore modeling approach that uses fragments placed with Multiple Copy Simultaneous Search (MCSS) to generate high-performing pharmacophore models in the context of experimentally determined, as well as modeled GPCR structures. Moreover, we have addressed the oft-neglected topic of pharmacophore model se-lection via development of a cluster-then-predict machine learning workflow. Herein score-based pharmaco-phore models were generated in experimentally determined and modeled structures of 13 class A GPCR and resulted in pharmacophore models exhibiting high enrichment factors when used to search a database containing 569 class A GPCR ligands. In addition, classification of pharmacophore models with the best performing cluster-then-predict logistic regression classifier resulted in positive predictive values (PPV) of 0.88 and 0.76 for selecting high enrichment pharmacophore models from among those generated in experimentally determined and modeled structures, respectively.
引用
下载
收藏
页数:17
相关论文
共 50 条
  • [21] Structure-based pharmacophore modeling and virtual screening to identify novel inhibitors for anthrax lethal factor
    Liao, Huang-Sheng
    Liu, Hsuan-Liang
    Chen, Wei-Hsi
    Ho, Yih
    MEDICINAL CHEMISTRY RESEARCH, 2014, 23 (08) : 3725 - 3732
  • [22] Ligand and Structure-Based Pharmacophore Modeling for the Discovery of Potential Human HNMT Inhibitors
    Elumalai, Pavadai
    Liu, Hsuan-Liang
    Zhou, Zheng-Li
    Zhao, Jian-Hua
    Chen, Wilson
    Chuang, Chih-Kuang
    Tsai, Wei-Bor
    Ho, Yih
    LETTERS IN DRUG DESIGN & DISCOVERY, 2012, 9 (01) : 17 - 29
  • [23] Pharmacophore modeling and structure-based virtual screening for a novel “switch region” target of bacterial RNA polymerase
    Yu-Sheng Li
    Lu Zhou
    Xiang Ma
    Hang Song
    Xiang-Yang Tang
    Medicinal Chemistry Research, 2012, 21 : 642 - 652
  • [24] Structure-based pharmacophore design and virtual screening for novel angiotensin converting enzyme 2 inhibitors
    Rella, M
    Rushworth, CA
    Guy, JL
    Turner, AJ
    Langer, T
    Jackson, RM
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2006, 46 (02) : 708 - 716
  • [25] Pharmacophore modeling and structure-based virtual screening for a novel "switch region" target of bacterial RNA polymerase
    Li, Yu-Sheng
    Zhou, Lu
    Ma, Xiang
    Song, Hang
    Tang, Xiang-Yang
    MEDICINAL CHEMISTRY RESEARCH, 2012, 21 (05) : 642 - 652
  • [26] Structure-based and shape-complemented pharmacophore modeling for the discovery of novel checkpoint kinase 1 inhibitors
    Xiu-Mei Chen
    Tao Lu
    Shuai Lu
    Hui-Fang Li
    Hao-Liang Yuan
    Ting Ran
    Hai-Chun Liu
    Ya-Dong Chen
    Journal of Molecular Modeling, 2010, 16 : 1195 - 1204
  • [27] Structure-based and shape-complemented pharmacophore modeling for the discovery of novel checkpoint kinase 1 inhibitors
    Chen, Xiu-Mei
    Lu, Tao
    Lu, Shuai
    Li, Hui-Fang
    Yuan, Hao-Liang
    Ran, Ting
    Liu, Hai-Chun
    Chen, Ya-Dong
    JOURNAL OF MOLECULAR MODELING, 2010, 16 (07) : 1195 - 1204
  • [28] Identification of Novel TRPC5 Inhibitors by Pharmacophore-Based and Structure-Based Approaches
    Li, Shuxiang
    Zhang, Shuqun
    Chen, Dingyuan
    Jiang, Xuan
    Liu, Bin
    Zhang, Hongbin
    Rachakunta, Munikishore
    Zuo, Zhili
    COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2020, 87
  • [29] Molecular modeling of Plasmodium falciparum peptide deformylase and structure-based pharmacophore screening for inhibitors
    Manhas, Anu
    Kumar, Sivakumar Prasanth
    Jha, Prakash Chandra
    RSC ADVANCES, 2016, 6 (35): : 29466 - 29485
  • [30] From the protein's perspective: the benefits and challenges of protein structure-based pharmacophore modeling
    Sanders, Marijn P. A.
    McGuire, Ross
    Roumen, Luc
    de Esch, Iwan J. P.
    de Vlieg, Jacob
    Klomp, Jan P. G.
    de Graaf, Chris
    MEDCHEMCOMM, 2012, 3 (01) : 28 - 38